XML 45 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Combinations (Tables)
6 Months Ended
Jun. 30, 2016
Business Acquisition [Line Items]  
Schedule of Purchase Price Allocation
 Estimated Fair Value
(in millions) 
  
Cash paid to shareholders $12,366.7
Fair value of stock issued to shareholders19,353.20
Fair value of partially vested stock options and RSUs assumed497.6
Contingent consideration payable166
 ___________________
Total Purchase Consideration $ 32,383.5
 ___________________
  
Baxalta  
Business Acquisition [Line Items]  
Schedule of Purchase Price Allocation
  
 Preliminary fair value
 $’M
ASSETS 
Current assets: 
Cash and cash equivalents 583.2
Accounts receivable, net 1,382.8
Inventories 5,341.1
Other current assets 362.2
 _______________
Total current assets 7,669.3
  
Non-current assets: 
Property, plant and equipment, net 5,687.7
Investments 128.2
Goodwill 6,106.4
Other intangible assets, net 
- Currently marketed products 24,550.0
- In-Process Research and Development (“IPR&D”) 2,940.0
- Contract based arrangements 72.2
Other non-current assets 103.3
 _______________
Total assets 47,257.1
 _______________
LIABILITIES AND EQUITY 
Current liabilities: 
Accounts payable and accrued expenses 1,509.5
Other current liabilities 15.4
  
Non-current liabilities: 
Assumed indebtedness 5,424.9
Deferred tax liability 6,831.7
Other non-current liabilities 1,092.1
 _______________
Total liabilities 14,873.6
 _______________
  
Preliminary fair value of identifiable assets acquired and liabilities assumed 32,383.5
 _______________
Consideration 
Preliminary fair value of purchase consideration 32,383.5
Business Acquisition, Pro Forma Information
     
 3 Months Ended June 30,6 Months Ended June 30,
 2016201520162015
 $’M$’M$’M$’M
 ____________________________________________________________
Revenues3,484.12,986.66,741.45,836.0
     
Net income/(loss) from continuing operations716.0(401.4)1,177.3(976.1)
 ____________________________________________________________
     
Per share amounts:    
Net income/(loss) from continuing operations per share - basic$ 0.81$ (0.45)$ 1.33$ (1.09)
     
Net income/(loss) from continuing operations per share - diluted$ 0.81$ (0.45)$ 1.32$ (1.09)
 ____________________________________________________________
Dyax  
Business Acquisition [Line Items]  
Schedule of Purchase Price Allocation
  
 Fair value
 $’M
ASSETS 
Current assets: 
Cash and cash equivalents241.2
Accounts receivable, net13.3
Inventories 20.2
Other current assets8.1
 _______________
Total current assets282.8
  
Non-current assets: 
Property, plant and equipment, net5.8
Goodwill2,727.9
Other intangible assets, net 
- Currently marketed products 135.0
- IPR&D 4,100.0
- Contract based royalty arrangements425.0
Other non-current assets28.3
 _______________
Total assets7,704.8
 _______________
LIABILITIES AND EQUITY 
Current liabilities: 
Accounts payable and accrued expenses30.0
Other current liabilities1.7
  
Non-current liabilities: 
Deferred tax liability1,341.7
Other non-current liabilities1.4
 _______________
Total liabilities1,374.8
 _______________
  
Preliminary fair value of identifiable assets acquired and liabilities assumed6,330.0
 _______________
Consideration 
Preliminary fair value of purchase consideration 6,330.0
Business Acquisition, Pro Forma Information
     
 3 Months Ended June 30,6 Months Ended June 30,
 2016201520162015
 $’M$’M$’M$’M
 ____________________________________________________________
Revenues2,429.11,584.04,144.33,092.8
     
Net income/(loss) from continuing operations88.6128.3490.2406.3
 ____________________________________________________________
     
Per share amounts:    
Net income/(loss) from continuing operations per share - basic$ 0.13$ 0.22$ 0.77$ 0.69
     
Net income/(loss) from continuing operations per share - diluted$ 0.13$ 0.22$ 0.77$ 0.69
 ____________________________________________________________
NPS Pharma  
Business Acquisition [Line Items]  
Schedule of Purchase Price Allocation
  
 Fair value
 $’M
  
ASSETS 
Current assets: 
Cash and cash equivalents41.6
Short-term investments67.0
Accounts receivable33.4
Inventories89.4
Other current assets11.1
 _______________
Total current assets242.5
  
Non-current assets: 
Property, plant and equipment, net4.8
Goodwill 1,551.0
Other intangible assets 
- Currently marketed products 4,640.0
- Royalty rights (categorized as "Other amortized intangible assets" )353.0
 _______________
Total assets 6,791.3
 _______________
LIABILITIES 
Current liabilities: 
Accounts payable and other current liabilities75.7
Short-term debt27.4
  
Non-current liabilities: 
Long-term debt, less current portion78.9
Deferred tax liabilities 1,385.2
Other non-current liabilities4.5
 _______________
 Total liabilities 1,571.7
 _______________
  
Fair value of identifiable assets acquired and liabilities assumed 5,219.6
  
Consideration_______________
Cash consideration paid 5,219.6
 _______________
Business Acquisition, Pro Forma Information
 3 Months Ended to June 30,6 Months Ended to June 30,
 20152015
 $’M$’M
 ______________________________
Revenues1,557.63,075.9
   
Net income from continuing operations167.8526.6
 ______________________________
   
Per share amounts:  
Net income from continuing operations per share - basic$0.28$0.96
   
Net income from continuing operations per share - diluted$0.28$0.95
 ______________________________